Matrix metalloproteinase activation has been described in large cell lung carcinoma, where elevated CAV1 expression correlates with advanced stages of lung cancer as well as increased MMP9/MMP2 expression and activity. The gene discussed is MMP9; the disease is lung carcinoma.